A Study of HMPL-306 in Patients With IDH1 and/or IDH2 Mutation of Relapsed/Refractory Myeloid Leukemia/Neoplasms

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
Phase I, multicenter study to evaluate the safety, pharmacokinetics, pharmacodynamics and efficacy of HMPL-306 in Patients of Relapsed/Refractory Myeloid Leukemia/Neoplasms with IDH1 and/or IDH2 Mutation.
Epistemonikos ID: 0d82e1ac0a9adfe26628524b93164513e9c609c0
First added on: May 07, 2024